Pulmonary Hypertension Trial, Recruiting NCT07176260 Sponsor: University Hospital, Strasbourg, France Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07176260
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older and have been diagnosed with a specific type of high blood pressure in the lungs (called pre-capillary pulmonary hypertension), confirmed by a procedure that measures pressure in the heart.
  • You have been diagnosed with one of three specific types of this condition: pulmonary arterial hypertension (PAH), pulmonary hypertension linked to chronic lung disease or low oxygen levels, or a type caused by old blood clots in the lungs (CTEPH).
  • You are already scheduled for a routine check-up or a heart pressure measurement procedure at the study centre.
  • You are willing and able to understand and sign a consent form agreeing to take part and allow your data to be used.

Who may not be able to join:

  • You have a type of lung high blood pressure that is caused by a back-up of pressure from the left side of the heart (confirmed with trial site).
  • You have a medical condition that would make it unsafe to have a blood sample taken, such as severe anaemia or a blood clotting problem.
  • You are already taking part in another clinical trial that involves treatments or tests related to how cells produce energy or handle stress (confirm with trial site).
  • You are not able or not willing to sign a consent form to take part.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marianne RIOU, Hôpitaux Universitaires de Strasbourg

Phone: + 33 3 69 55 11 45

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 September 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Blood Cell Mitochondrial Function and Respiration and Oxidative Stress Markers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov